Skip to main content
Clinical Trials/NCT00350909
NCT00350909CompletedPhase 2

Brief Intervention for Drug Abusing Students

University of Minnesota2 sites in 1 country160 target enrollmentStarted: September 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
160
Locations
2
Primary Endpoint
Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.

Study Overview

Brief Summary

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Detailed Description

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Specifically, we propose a randomized clinical trial to evaluate the efficacy of a cognitive-behavioral therapy on key process and outcome dimensions among school-based youth with mild-to-moderate drug abuse (MMDA). The experimental treatment is designated Brief Cognitive Behavioral Intervention (BCBI) given its theoretical foundation in stage of change theory used to coordinate modules on Rational-Emotive Therapy and Problem Solving Therapy. BCBI will be compared against a second experimental treatment that consists of BCBI and a single parent session (BCBI+P) and an assessment only condition (control). The importance of clarifying mechanisms in drug treatment research will be explored with respect to a limited number of treatment and individual factors that have emerged as promising mediating and moderating factors, such as cognitive and problem solving factors, parenting practices, and peer group influences.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
13 Years to 19 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • student at a local school
  • meets DSM-IV criteria for a substance abuse disorder for at least one drug
  • student and parent both agree to participate in the intervention study

Exclusion Criteria

  • meets criteria for at least one DSM-IV substance dependence disorder
  • meets criteria for a psychotic disorder or a learning disability

Outcomes

Primary Outcomes

Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.

Time Frame: 1 year post treatment

Secondary Outcomes

  • HIV and sexual risk behaviors at the same time period.(1 year post treatment)

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials